Femasys Inc. stock is down -30.79% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 December’s closed higher than November. 100% of analysts rate it a buy.
Femasys Inc. focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec. FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing, also commercializes FemVue saline-air device.